Skip to main content
OpenTrials
Completed

NCT Number: NCT05788367

Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy

The aim of this study is to compare PENG and ISB after shoulder arthroscopy for postoperative pain management after shoulder arthroscopy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mohammed Fouad Mohamed Algyar

Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt

About this study

Shoulder arthroscopy is a common procedure done is orthopedics for many surgical indications as rotator cuff tears, stiffness and instability. This procedure has a well - documented postoperative pain. To improve the outcome after surgery, effective pain control is needed.

Various methods are used for postoperative pain management. Intravenous opioid agents are among them, but they may cause undesirable side effects, such as respiratory depression, sedation, constipation, allergic reaction, nausea, and vomiting. Thus, alternative techniques are preferred.

Interscalene brachial plexus blocks (ISBPBs) are often used to provide perioperative analgesia and anesthesia for shoulder surgery. They target nerve roots C4-C6 and thereby provide regional analgesia to the shoulder and upper arm. Although ISBPBs are often performed in combination with general anesthesia (GA) to enhance postoperative analgesia, they are also sometimes used as a sole means of anesthesia.

The pericapsular nerve group (PENG) block is an ultrasound-guided approach, first described by Giron-Arango et al. for the blockade of the articular branches of the femoral, obturator and accessory obturator nerves that provide sensory innervation to the anterior hip capsule. It has been successfully used as an alternative regional anaesthesia technique for the management of acute pain after hip fracture, and for analgesia after elective hip surgery

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Body mass index < 40 kg/m2
  • American Society of Anesthesiologists (ASA) physical status I-II
  • posted for elective shoulder arthroscopy

Exclusion criteria

  • Known allergy to local anesthetics
  • allergy to all opioid medications
  • diagnostic shoulder arthroscopic procedures
  • patients with chronic opioids use and coagulopathy

Treatment and study plan

The pericapsular nerve group

Procedure

patients received Ultrasound guided pericapsular nerve group block using 20 ml of bupivacaine 0.5%

Interscalene brachial plexus block

Procedure

patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5% before induction of general anesthesia

Primary outcomes

  1. Asses The postoperative opioid consumption

    Time frame: 24 hours postoperatively

    the postoperative opioid consumption during the procedure

Sponsors and collaborators

Lead sponsor

Kafrelsheikh University

Other

Registry information

Official study title

Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy: A Randomized Controlled Study

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Mar 28, 2023
Registry last updated
Feb 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.